Stay updated with breaking news from Engineering Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The focus of the fund is to promote diversity and equity through a renewed emphasis on our common humanity.
ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System. ...
Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?
FDA clearance would allow the Company to market its breakthrough therapy to improve or restore hand and arm function after spinal cord injury in the USTHIS PRESS RELEASE CONTAINS INSIDE INFORMATION...
The focus of the fund is to promote diversity and equity through a renewed emphasis on our common humanity.